T-lymphocyte clone specific for pancreatic islet antigen.

Area of Science:

• Immunology
• Endocrinology
• Transplantation Biology

Background:

• The nonobese diabetic (NOD) mouse model is crucial for studying autoimmune diabetes.
• T-lymphocytes play a significant role in autoimmune diseases, including type 1 diabetes.
• Islet cell antigens are key targets in autoimmune responses against pancreatic beta cells.

Purpose of the Study:

• To investigate the role of a specific T-lymphocyte clone (BDC-2.5) in islet transplantation.
• To determine the tissue specificity of the BDC-2.5 T-lymphocyte clone's action.
• To understand the in vivo function of islet-specific T-lymphocytes in an autoimmune context.

Main Methods:

• Derivation of a CD4+ T-lymphocyte clone (BDC-2.5) from NOD mice.
• In vitro proliferation and lymphokine production assays in response to antigen-presenting cells.
• In vivo islet transplantation experiments with and without the BDC-2.5 T-lymphocyte clone.
• Comparative transplantation of pituitary tissue to assess tissue specificity.

Main Results:

• The BDC-2.5 T-lymphocyte clone proliferated and produced lymphokines upon stimulation with islet cell antigens.
• In vivo, the presence of BDC-2.5 T-lymphocytes led to the complete destruction of transplanted islet tissue.
• Transplanted pituitary tissue remained unaffected by the BDC-2.5 T-lymphocyte clone, indicating tissue specificity.

Conclusions:

• The BDC-2.5 T-lymphocyte clone mediates a potent, tissue-specific destruction of islet grafts.
• These findings suggest that islet-specific T-lymphocytes are key effectors in the autoimmune destruction of pancreatic beta cells.
• This study provides insights into the mechanisms underlying autoimmune diabetes and potential therapeutic targets.